BIOMAT Database Logo BIOMAT Database Logo

Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies. 2017

Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

The HIPK2 (serine/threonine homeodomain-interacting protein kinase 2) is a "caretaker" gene, its inactivation increases tumorigenicity while its activation inhibits tumor growth. This report reviews the anti-tumorigenic mechanisms of HIPK2, which include promotion of apoptosis, inhibition of angiogenesis in hypoxia, prevention of tumor invasion/metastasis and attenuation of multidrug resistance in cancer. Additionally, we summarize conditions or factors that may increase HIPK2 activity.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases

Related Publications

Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
April 2010, Biochemical and biophysical research communications,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2).
January 2014, PloS one,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Programmed cell death 4 protein (Pdcd4) and homeodomain-interacting protein kinase 2 (Hipk2) antagonistically control translation of Hipk2 mRNA.
July 2015, Biochimica et biophysica acta,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.
June 2005, FEBS letters,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.
September 2003, The Journal of biological chemistry,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
October 1999, Proceedings of the National Academy of Sciences of the United States of America,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy.
August 2018, Cell death & disease,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Protein kinase Cs in lung cancer: a promising target for therapies.
September 2013, Journal of cancer research and therapeutics,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.
January 2017, Journal of molecular biology,
Yuanyuan Feng, and Lihong Zhou, and Xiaoting Sun, and Qi Li
The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
July 2015, The Journal of biological chemistry,
Copied contents to your clipboard!